Home » Bavarian Nordic Cuts Outlook on FDA Permit Delay
Bavarian Nordic Cuts Outlook on FDA Permit Delay
Danish biotech firm Bavarian Nordic lowered its financial guidance for 2009 on Friday
because of a delayed U.S. permit for delivery of its Imvamune smallpox vaccine, knocking its shares 7 percent lower.
ForexYard
ForexYard
Upcoming Events
-
07May
-
14May
-
30May